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Abstract 
Histological assessments of synovial tissues from patients with failed CoCr alloy hip prostheses 
demonstrate extensive infiltration and accumulation of macrophages, often loaded with large 
quantities of particulate debris. The resulting adverse reaction to metal debris (ARMD) 
frequently leads to early joint revision. Inflammatory response starts with the recruitment of 
immune cells and requires the egress of macrophages from the inflamed site for resolution of 
the reaction.  Metal ions (Co2+ and Cr3+) have been shown to stimulate the migration of T 
lymphocytes but their effects on macrophages motility are still poorly understood. To 
elucidate this, we studied in vitro and in vivo macrophage migration during exposure to cobalt 
and chromium ions and nanoparticles. We found that cobalt but not chromium significantly 
reduces macrophage motility. This involves increase in cell spreading, formation of 
intracellular podosome-type adhesion structures and enhanced cell adhesion to the 
extracellular matrix (ECM). The formation of podosomes was also associated with the 
production and activation of matrix metalloproteinase-9 (MMP9) and enhanced ECM 
degradation. We showed that these were driven by the down-regulation of RhoA signalling 
through the generation of reactive oxygen species (ROS). These novel findings reveal the key 
mechanisms driving the wear/corrosion metallic byproducts-induced inflammatory response 
at non-toxic concentrations. 
 
 








  Graphical abstract 
1. Introduction  
Total hip arthroplasty (THA) restores mobility and improves the quality of life in patients 
suffering from severe osteoarthritis or femoral fractures. In 2015, 83,886 primary hip 
replacements were conducted in the UK with 8,367 hip revision procedures performed largely 
due to the aseptic loosening, pain, implant wear and adverse reaction to metal debris (ARMD) 
[1]. It is expected that these numbers will keep rising due to the ageing of population and an 
increasing number of implanted prostheses.   
Since the mid-1980s, over one million metal-on-metal (MoM) hip replacement prostheses, 
made from a cobalt chromium (CoCr) alloy, have been implanted worldwide [2]. These were 
used for joint replacements in younger, more active patients [3] due to the adverse response 
to polyethylene particles from the first-generation metal-on-polyethylene (MoP) bearings or 
from the fracture risk of a ceramic head. However, concerns for these implants became 
increasingly prominent due to reports of ARMD [4, 5]. The metal wear debris and released 
ions (Co2+ and Cr3+), which are widely generated in MoM bearings of hip implants, are now 
also found in patients with MoP bearings due to the mechanically assisted crevice corrosion 





Wear and corrosion particles retrieved from tissues surrounding MoM devices have been 
shown to be predominantly in the nanometer-size range [4, 9]; the particles are generally 
smaller than 50 nm (range 6-834 nm) with round or irregular morphologies. The wear particles 
have been generated in hip simulators to have similar size distribution and morphology as 
recorded clinically, however the in vitro studies so far have not established the mechanism 
behind the adverse local response to these wear products, such as aseptic chronic 
inflammation and pseudotumour formation [9-12], which is closely associated with pain and 
implant failure.  
Prolonged inflammation results in ARMD at the implant site. First, wear particles and ionic 
corrosion products are detected and phagocytosed mainly by the tissue-resident 
macrophages [10] and if phagocytosed in a large number, these wear particles can activate 
macrophages to release an array of cytokines and chemokines to alarm circulating leucocytes 
[13]. Leukocytes infiltrating the inflamed tissue, promote recruitment of neutrophils or 
monocytes that differentiate locally into macrophages, and potentiate the pro-inflammatory 
environment. At the same time, the resolution of the inflammatory response occurs by 
removing the dead neutrophils and the egress of inflammatory macrophages from the 
inflamed tissue to the nearest opening of the draining lymphatics [14]. The undesired 
response to a MoM implant are frequently found to show soft tissue failure characterized by 
macrophage predominant infiltration with their massive intake of wear particles [15]. Metal 
ions (Co2+ and Cr3+) have been shown to enhance the migration of T lymphocytes 
independently of circulating cytokines or chemokines resulting in an accumulation of T 
lymphocytes in the periprosthetic tissues of some patients with CoCr-based implants [16]. 
However, the mechanism behind the macrophage migration in the presence of both wear 
debris and ions is largely unknown.  
This study aims to reveal mechanism regulating macrophage migration during exposure to 
cobalt and chromium compounds, in order to understand the clinical manifestation of a 
chronic inflammatory response. We have shown that cobalt, but not chromium, affects the 
migration of macrophages through ROS and RhoA signalling pathways.   
2. Materials and methods 
2.1. Particles and ions  
Cobalt and chromium nanoparticles were purchased from American Elements (Los Angeles, 
CA, USA). Cobalt nanoparticles (CoNPs) were composed of 90% cobalt and 10% cobalt (II,III) 
oxide with a  molecular weight of 58.93 and had a diameter of 2-60 nm (data from the 
company). Chromium nanoparticles (CrNPs) were in the form of chromium oxide (Cr2O3) 
nanoparticles with a diameter of 10-30 nm (manufacturer data). Prior to use, the 
nanoparticles were washed in 100% ethanol for sterilisation and resuspended in sterile H20 at 
a concentration of 1 mg/ml using a sonicator (pulsed mode, 3 min). Stock solutions (0.1 M) of 
Co2+ and Cr3+ ions were freshly prepared by dissolving CoCl2·6H2O (99.5% purity; Sigma Aldrich) 
and CrCl3·6H2O (100.8% purity; Sigma Aldrich) in sterile H20. These solutions were sterilized by 
filtration through 0.2 μm pore size sterile syringe filter (Merck Millipore). Stock solutions of 
cobalt and chromium nanoparticles and ions were further diluted in cell culture medium to 
achieve the desired concentrations.       
 
2.2. Characterization of the cobalt and chromium nanoparticles  
 
Transmission Electron Microscopy (TEM; JEOL JEM-2010, Japan) was employed to observe the 
morphology of CoNPs and CrNPs as shown in Fig. S1. CoNPs and CrNPs were suspended in 





polydispersity index (PDI) and the surface charge of cobalt and chromium nanoparticles in 
1640 RPMI medium that were employed in this study were analysed by Zetasizer (Malvern 
Co., UK).  
 
2.3. Cell lines and culture preparation     
Human U937 monocytic cell line  
Cells from the U937 cell line (passage 6-25, donation from Dr Akihisa Mitani, Imperial College 
London, UK) were cultured in RPMI 1640 medium (ThermoFisher, USA) supplemented with 
10% FBS (Sigma, USA), 1.9 mM L-glutamine, 96 U/ml penicillin, 96 μg/ml streptomycin, 19 mM 
HEPES buffer, in a humidified atmosphere with 5% CO2 at 37°C. To induce differentiation into 
adherent macrophage-like cells, cells were treated with 50 ng/ml PMA (Phorbol 12-myristate 
13-acetate, Sigma Aldrich) for 48 h and followed by rest for a further 24 h in complete RPMI 
1640 medium prior to further experiments.  
Isolation and differentiation of bone marrow-derived macrophages 
Bone marrow-derived macrophages (BMDMs) were harvested, pooled and differentiated 
according to established standard protocols [17]. To review briefly, femurs and tibiae were 
obtained from 8 of 6–12-week-old C57BL/6 mice. All mice were cared for according to the UK 
Animal Scientific Procedures Act (1986) and by the Institutional Committee for Use and Care 
of Laboratory Animals. Experiments were performed under the UK Home Office Personal 
licence number I56EDA266 and the groups UK Home Office Project Licence number 70/7266. 
Bone marrow was flushed from femurs and tibiae and bone marrow cells were collected and 
differentiated in RPMI-1640 complete medium containing macrophage colony-stimulating 
factor (M-CSF, 50 ng/ml, R&D Systems, Minneapolis, MN, USA) for 7 days.  
2.4. Cytotoxicity assay   
A colourimetric assay, MTS, was performed to assess the effect of cobalt and chromium 
nanoparticles and ions on macrophage viability using the CellTiter 96® Aqueous One Solution 
Cell Proliferation Assay (Promega, Southampton, UK). Cells (U937 macrophages or BMDMs) 
were seeded at a concentration of 5×104 in 96-well plates. For vehicle control, cells were 
stimulated with complete RMPI medium. After incubation for 6 and 24 h, medium was 
aspirated and 100 μl of serum-free RPMI medium containing 10% MTS reagent was added to 
each well. Plates were subsequently incubated for 3 h at 37°C and the absorbance was read 
at 490 nm using an Infinite F50 plate reader (Tecan, Switzerland). Five replicates of each 
exposure were tested and the entire assay was repeated for three separate experiments. The 
cell viability was determined as a percentage of control cell viability.   
2.5. Cell motility and migration assays  
Single cell motility monitoring  
Macrophage migratory ability was first investigated using live cell imaging. Inverted 
microscope (Lumascope 720, Etaluma, USA) connected to a cell culture incubator was used 
for live cell imaging to visualise macrophage migration. Time-lapse images of migrating U937 
macrophages at a seeded density of 2×104 cells/cm2 in a 24-well plate were collected after 12 
h incubation with Co2+ (200 µM), Cr3+ (400 µM), CoNPs (100 µM) or CrNPs (400 µM). The 
application of different concentrations of Co2+, Cr3+, CoNPs and CrNPs, Table 1, was based on 
the highest concentration that could be delivered whilst maintaining high cell viability, 






  Table 1. Concentration of cobalt and chromium applied during the migration tests  
 
Images were captured every 5 min for 6 h. Migratory properties of individual cells identified 
from the time-lapse images were then analysed using ImageJ software (n=25 cells / condition).  
Transwell cell migration assay 
Cell migration was also investigated using 6.5 mm Transwell chambers with 8 μm pores 
(Costar, Corning, NY, USA). Briefly, 2×105 harvested U937 macrophages or BMDMs in serum 
free RPMI 1640 medium were added to the upper chamber of the insert. The lower chamber 
was filled with 600 µl RPMI 1640 medium with 10% FBS to encourage cell migration down the 
FBS chemotactic gradient. Cells migration was analysed over a 6-hour period in the presence 
of Co2+ or Cr3+ that was added to both the upper and lower well at the required concentration 
or following 2-hour pretreatment with CoNPs or CrNPs (Table 1). After 6 hours treatment, cells 
remaining on the membrane were fixed with 4% paraformaldehyde (Sigma, USA), stained with 
crystal violet (Sigma, USA) and counted.  
In vivo macrophage migration assay and FACS (flow cytometry) analysis  
To demonstrate the validity of the in vitro studies, the in vivo effect of cobalt ions on mouse 
macrophage migration was studied. 20 WT C57BL/6 mice were first injected intraperitoneally 
with 1 ml of 4% thioglycollate (Sigma, USA) to recruit macrophages into the peritoneal cavity. 
After 4 days, the mice were injected intraperitoneally with 5 µg of CoNPs (10 mice) or PBS (10 
control mice). After 12 h, 5 mice from each group were injected with LPS (250 μl; 5 μg/ml) 
intraperitoneally to induce macrophages migration towards the regional lymph nodes; the 
remaining 5 mice from each group were injected intraperitoneally with PBS (250 μl) as blank 
control. After 4 h, the peritoneal cells were harvested by lavage and counted. The 
macrophages in the lavage were quantified by flow cytometry. Cell suspensions were pre-
incubated with anti–CD16/CD32 mAb to block FcγRII/III receptors (BD Pharmingen) on ice for 
15 min. After washing the suspension, cells were stained with PE/Cy5 anti-mouse CD11b 
antibody (Abcam, UK) and FITC anti-mouse F4/80 antibody (Abcam, UK). Stained cells were 
washed and re-suspended in 200 μl of PBS and analysed using a flow cytometer (BD ACCURI 
C6) and FlowJo software (TreeStar).        
2.6. Scanning electron microscope (SEM) analysis 
U937 macrophages on the coverslips were fixed in 2.5% glutaraldehyde (Sigma, USA) for 2 h 
and dehydrated in graded ethanol (50%, 70%, 80%, 90%, 95%, and 100%; 10 min for each). 
The samples were transferred to critical-point drying with hexamethyldisilazane (Sigma, USA) 
then coated with a 5 nm thick layer of gold–palladium alloy. The SEM images were obtained 
with a scanning electron microscope (FEI Quanta 200) at a low voltage (∼1 kV).    





Treated cells (U937 macrophages or BMDMs) were fixed with 4% paraformaldehyde (Sigma, 
USA) and washed and permeabilized with 0.5% Triton X-100 and rinsed 3 times with PBS. 
Nonspecific binding sites were blocked by adding PBS with 1% BSA. The adhesion protein, 
vinculin, was labelled by incubation at 4°C, overnight with mouse monoclonal anti-vinculin 
primary antibody, clone hVIN-1 (1:400, Sigma, USA). Cells were then washed and incubated 
for 1 h at room temperature in Alexa 488 conjugated anti-Mouse IgG as Secondary Antibody 
(1:1000, Invitrogen, USA). In separate samples, cellular α-tubulin and acetylated α-tubulin 
were labelled using rabbit polyclonal anti-α tubulin antibody (1:200, Abcam, UK) and mouse 
anti-acetylated tubulin, clone 611B-1 (1:2000; Sigma-Aldrich, USA) respectively with Alexa 488 
secondary antibodies as above. 
To simultaneously label the F-actin, the samples were incubated for 30 mins with 200 μl of 
rhodamine-conjugated phalloidin (Molecular Probes, USA) in a humidified chamber at room 
temperature in the dark. Cell nuclei were stained by incubation with 5 μg/ml DAPI (Dojindo, 
USA) followed by two PBS rinses. Slides were then visualized with a fluorescence microscope 
(SP2, Leica, Germany) with x63 objective. Slides were also imaged on a microscope (710 ELYRA 
PS.1, Zeiss, Germany) with a ×63/1.4 NA objective for structural illumination microscopy.  
2.8. Cell adhesion assay  
U937 macrophages were seeded at a concentration of 2×105 cells/well into a 24-well plastic 
cell culture plate coated with 2% gelatin and treated with 100 µM, 200 µM or 300 µM Co2+. 
After 30 min of incubation, cell culture medium in each well were aspirated and gently rinsed 
2 times with warm PBS. Adherent cells of were then imaged (10 fields of each well were 
randomly selected) with an inverted microscope (DCF420, Leica, Germany) and counted.  
2.9. Proteolytic activity measurement  
In vitro ECM degradation assay 
U937 macrophages were seeded onto coverslips coated with FITC-conjugated gelatin, as part 
of an in vitro ECM degradation assay, as previously described [18]. Briefly, glass coverslips 
were coated with 0.2 mg/ml FITC-gelatin (Molecular Probes, USA) in PBS and fixed with 0.5 % 
glutaraldehyde, washed six times with PBS, then washed once with 70% ethanol/PBS and once 
with medium. U937 macrophages (1 × 105/well) were plated onto the coverslips and 
incubated at 37 °C in the presence of Co2+ (200 µM), CoNPs (100 µM), Cr3+ (400 µM) or CrNPs 
(400 µM) for 24 hours,  then fixed, processed for F-actin staining with rhodamine-conjugated 
phalloidin, and observed as described above. The coverslips were examined using a confocal 
microscope (SP2, Leica, Germany) and the total area that was degraded was measured using 
ImageJ software [18]. The matrix degradation index was calculated as the ratio between the 
area of gelatin matrix degraded by treated cells to that degraded by untreated cells. 
Gelatin zymography 
Conditioned media collected from cells treated by cobalt ions (100 µM, 200 µM, 300 µM) and 
nanoparticles (20 µM, 50 µM and 100 µM) for 24 hours were used for gelatin zymography. 
The supernatants were subjected to electrophoresis in an 8% SDS-PAGE gel co-polymerized 
with gelatin (1 mg/ml, Sigma, USA). The gelatinolytic activities were detected as transparent 
bands against the background of Coomassie Brilliant Blue-stained gelatin and quantified using 
ImageJ software.  
2.10. ROS measurements 
ROS formation was measured using 5-(and 6-)-chloromethyl-2’7’-dichlorodihydrofluorescein 
diacetate (CM-H2DCFDA, Life technologies, USA). Cells were cultured in black 96-well plates 





briefly washed with warmed PBS. CM-H2DCFDA was dissolved in anhydrous DMSO to a final 
concentration of 1 mM and diluted further in Hank's balanced salt solution (HBSS, 
ThermoFisher, USA). Cells were exposed to 1 μM CM-H2DCFDA for 30 min at 37 °C in the dark. 
Fluorescence was read at an excitation of 485/20 nm with emission 528/20 nm using a 
microplate reader (Synergy HT Multi-Mode, Biotek, USA).  
2.11. Protein extraction and Immunoblotting 
All lysis buffers were supplemented with 1% protease inhibitor (Sigma Aldrich, USA).  Protein 
extracts were resolved  using  gradient  precast SDS – polyacrylamide gel electrophoresis 
(Biorad Laboratories Inc, USA), and then electro-transferred onto a nitrocellulose membrane 
by using Trans-Blot® Turbo™ Transfer System (Biorad Laboratories Inc, USA) for immunoblot 
analysis. Antibody probing was done as per manufacturers’ instructions Antibodies used 
include anti-RhoA antibody (1:1000, Abcam, UK),  anti-CDC42 antibody (1:1000, Abcam, UK), 
anti-Rac1 antibody (1:1000 Abcam, UK), anti-phospho-MYPT1 (Thr696) antibody (1:1000, Cell 
Signaling Technology, USA), anti-myosin light chain (phospho S20) antibody (1:1000, Abcam, 
UK), anti-GAPDH antibody (1:2000, Abcam, UK). Secondary antibodies either IRDye® 800CW 
Goat anti-Mouse IgG (LI-COR, USA) or IRDye® 800CW Goat anti-Rabbit IgG (LI-COR, USA) were 
used with dilution of 1:15000. Specific protein bands were detected using Odyssey® CLx 
Imaging System (LI-COR, USA). 
2.12. Data analysis 
All data are expressed as the mean ± SEM from independent repeat experiments (N=3) unless 
otherwise stated. The number of repeat measurement per experiment (n) is indicated in each 
figure. All statistical differences were analysed with one-way ANOVA or Kruskal-Wallis test 
with Dunn's Multiple Comparison Test unless otherwise stated (SPSS Inc., Chicago, IL, USA). A 





















3.1 Cobalt (II) ions and nanoparticles inhibit U937 macrophage random migration  
To directly measure the impact of cobalt and chromium on macrophage motility in vitro, we 
first performed time-lapse imaging of U937 macrophages after 12 hours of cobalt or 
chromium treatment using non-cytotoxic concentrations (Supplementary Fig. S2). Fig. 1A-E 
shows the migration paths for 25 individual cells in each treatment group. The total path 
length of cells treated with Co2+ and CoNPs were significantly shorter than those for untreated 
control cells (P<0.001, Fig. 1F). Treatment with Cr3+ or CrNPs had no significant effect on 
macrophage migration.  
Figure 1. Cobalt ions and nanoparticles reduce U937 macrophage random migration. (A-E): 
Detailed migration trajectories of cells (n=25) over a 6-hour period following treatment with 
cobalt or chromium. Individual tracks were transposed so that each of the cells started at the 
same origin.  (F) Net cell migration length for each treatment with values indicating 
mean+SEM for N=3 experiments (n=25 cells/condition/experiment). Statistical differences 
from untreated control are based on one-way ANOVA with Bonferroni post-test; ***P < 0.001.    
3.2 Cobalt inhibits U937 macrophages and BMDMs transmigration   
Using transwell migration assay we confirmed the results observed using random cell 
migration (Fig. 1). The ability of U937 macrophages to migrate through the porous transwell 
membrane was significantly impaired by pre-treatment with either Co2+ or CoNPs (Fig. 2). 
Exposure to Co2+ and CoNPs, reduced the number of transmigrating U937 macrophages by 
approximately 62% and 55%, respectively, whilst for BMDMs, the corresponding reductions 
in migration were approximately 45% and 53%, respectively (Fig. 2B). Incubation with Cr3+ and 
CrNPs had no statistically significant effect on the cell migration relative to untreated controls 





Figure 2. Cobalt ions and nanoparticles reduce transmigration of U937 macrophages and 
BMDMs. (A) Representative images of migrated U937 macrophages and BMDMs treated by 
Co2+, CoNPs, Cr3+ and CrNPs (Scale bar = 100 µm). (B) Quantifications of the migration assay 
based on three independent experiments. Values represent mean + SEM. N=3. For each 
experiment, 10 random fields were imaged for each treatment (n=10). Statistically significant 
differences are indicated relative to untreated control based on one-way ANOVA with 
Bonferroni post-test; ***P < 0.001.     
3.3 CoNPs inhibit macrophage migration in vivo  
To determine whether cobalt affects macrophage migration in vivo, we quantified the number 
of macrophages in the mouse peritoneal cavity before and after LPS stimulation in mice with 
or without cobalt pre-treatment. As neither Cr3+ nor CrNPs showed any significant effect on 
macrophage migration in vitro, only cobalt exposure was examined during the in vivo study. 
Mice were injected with cobalt nanoparticles to mimic the generated cobalt in vivo dissolution 
products. Harvested peritoneal macrophages were identified by a flow cytometry gating 
strategy according to their size and granularity (Fig. 3A), CD11b and F4/80 surface marker 
expression (Fig. 3B). In mice not stimulated with LPS, the CoNPs pre-treatment had no 
significant effect on the number of peritoneal macrophages compared with control group (PBS 
only). After LPS stimulation, a marked efflux of peritoneal macrophages (by approximately 
60%, Fig. 3C) from the cavity of control mice (PBS only) was observed, consistent with 
previously published work [19].  In mice pre-treated with CoNPs, the LPS stimulation had no 
significant effect in inducing macrophages efflux, with the number of macrophages remained 
at similar levels to the CoNPs group without LPS treatment, which indicated that the ability of 





Figure 3. Macrophage migration in vivo is inhibited by CoNPs. Representative FACS analysis 
images showing the gating strategy to identify the peritoneal macrophages based on (A) cell 
size and granularity, (B) CD11b and F4/80 surface markers expression. (C) Number of 
harvested macrophages from treated mice from each group, with data normalised to PBS 
control group (mice injected with PBS twice). Statistically significant differences were 
determined by one-way ANOVA and Bonferroni’s multiple comparison test (n = 5 mice per 
treatment, ** indicates difference from PBS control (PBS only) P < 0.01; # indicates difference 
between CoNPs and PBS treatment with LPS, P < 0.05).  
3.4 Cobalt modulate microtubule acetylation in U937 macrophages   
To initiate cell migration, internal forces developed by the actin cytoskeleton are transmitted 
through cell-substrate adhesion sites while a dynamic turnover of adhesion complexes occurs 
[20]. Disruption in the cell migration indicates either an alteration in this force transmission 
or changes in the cell adhesion strength. Uptake of metal particles can impede the force 
balance between the microtubule (MT) and F-actin by inhibiting MT polymerization in 
epithelial cells [21]. Therefore, we investigated whether microtubule or cytoskeletal 
impairment causes the inhibition of macrophage migration. The MT structure of the control 
and treated cells are shown in Fig. 4A. Both Co2+ and CoNPs induced a significant increase in 
U937 macrophage alpha tubulin acetylation, one of the basic components for MT biopolymer 
[22], confirmed by immunofluorescence staining (Fig. 4A, B) and Western Blot analysis (Fig. 
4C, D). In contrast, chromium ions had no significant effect on the MT organisation or 
acetylation while CrNPs slightly reduced the MT acetylation, although it was not statistically 
significant. We also investigated the effect of an inhibitor of a member of the histone 
deacetylase family, HDAC6, which regulates MT-dependent cell motility via mediating tubulin 
deacetylation [23]. HDAC6 overexpression induces a global deacetylation of D-tubulin, hence 
promoting cell chemotactic migration [23]. When U937 cell were treated with a HDAC6 
inhibitor, Tubastatin A (5µM), a hyperacetylation of tubulin was observed (Fig. 4A), showing 
much higher effect than the cobalt treatment. Tubastatin A also significantly reduced the 
number of migrating cells in a transwell migration assay, however only partially replicating the 
effect of cobalt treatment (Fig. 4E). This suggests that cobalt-mediated tubulin acetylation in 





Figure 4. Cobalt-induced hyper-acetylation of tubulin and its effect on macrophage migration. 
(A) Representative immunofluorescence confocal images of U937 macrophages treated with 
Co2+, CoNPs, Cr3+, CrNPs and Tubastatin A for 24 hours. Cells were stained for acetylated α-
tubulin (red) and α-tubulin (green). Scale bar represents 20 µm. Integrated fluorescent signal 
intensity for acetylated and non-acetylated tubulin in each cell was quantified and shown in 
(B) n=25; values represent mean + SEM; *P < 0.05; **P < 0.01; N=3. (C) Western blots for 
acetylated α-tubulin and α-tubulin for cells treated with cobalt, chromium, Tubastatin A for 
24 hours and (D) the corresponding quantification demonstrating increased total α-tubulin 
acetylation. Values represent mean + SEM; */*** indicate difference from control, 
P < 0.05/P < 0.001; ### indicates difference between Co2+ and Tubastatin A, P < 0.001; N=3. 
(E) Increased tubulin acetylation with Tubastatin A significantly reduced macrophage 
transwell migration. Values represent mean + SEM; *P < 0.05, **P < 0.01; N=3 experiments, 
n=10 fields of view per experiment. All statistically significant differences were determined by 











3.5 Cobalt ions and nanoparticles promote macrophage spreading and podosome 
formation, which are associated with increased cell adhesion 
Macrophage migration involves remodelling of the actin cytoskeleton associated with cell 
spreading, disassembly of existing focal adhesions, and formation of new cell-matrix 
interactions. SEM imaging revealed that both Co2+ and CoNPs significantly increased U937 
macrophage spreading with increase in lamellipodia protrusions around the cell periphery 
(Fig. 5A). In this case, CoNP-treatment had a significantly greater effect than Co2+ treatment 
(Fig. 5B). U937 macrophages expressed characteristic podosome-like punctate adhesion 
structures, characterised by an actin-rich core surrounded by vinculin adhesion proteins (Fig. 
5C). Treatment with either Co2+ or CoNPs significantly increased both the podosome number 
(Fig. 5D) and density within individual cells (Fig. 5E). Cobalt also significantly increased the 
percentages of cells forming podosomes in BMDMs (Fig. S4). Excessive formation of the 
adhesion complex can result in a strong anchorage of cells to the underlying substrate, 
thereby inhibiting cell migration [24]. Hence, we examined whether changes in macrophage 
morphology and podosome formation during cobalt treatment were associated with 
alterations in cell adhesion. U937 cells exposed to Co2+ showed an increased cell adhesion to 
the ECM in a concentration-dependent manner (Fig. 5F, G). This effect of Co2+ was not evident 
on BMDMs (data not shown), possibly due to differences in the speed of the cell adhesion to 
the matrix. Collectively, these results indicate that the cobalt-induced inhibition of 
macrophage migration is associated with cytoskeletal reorganisation, podosomes formation 






Figure 5. Reduced macrophage migration induced by cobalt is associated with increased cell 
spreading and podosome formation and cell adhesion to extracellular matrix.  (A) 
Representative SEM images of U937 macrophages incubated for 12 h with Co2+ (200 µM), 
CoNPs (100 µM), Cr3+ (400 µM) or CrNPs (400 µM) and untreated control. Scale bar indicates 
100 µm. (B) Quantification of projected cell area for each treatment. Values represent mean 
+ SEM for N=3 separate experiments with n=150 cells per experiment. Statistically significant 
differences from untreated control determined by one-way ANOVA and Bonferroni’s multiple 
comparison test. ***P < 0.001. (C) Representative confocal microscopy images showing 
appearance of punctate podosome adhesion structures consisting of actin core (red) and 
surrounded by vinculin (green) in U937 macrophages following treatment with cobalt or 
chromium as described in (A). Scale bar indicates 10 µm. Associated quantification of (D) 
podosome number/cell and (E) podosome density. n=150 cells for each group. Data with 





by Kruskal-Wallis test and Dunn's Multiple Comparison Test. ***P < 0.001; N=3. (F) 
Representative brightfield fields of view images showing that cobalt increased cell adhesion 
to ECM in a dose-dependent manner, where the scale bar indicates 100 µm, as quantified in 
(G) showing significantly increased numbers of adherent cells per field of view at 200 μM and 
300 μM. Data indicates mean + SEM for N=3 with n=10 fields of view per experiment. 
Statistical significance based on one way ANOVA and Bonferroni’s multiple comparison test; 
*P < 0.05, **P < 0.01.  
3.6 Cobalt-induced podosome formation in U937 macrophages stimulates ECM 
degradation  
Podosomes promote adhesion to the substrate and degrade the components of the ECM. To 
determine whether cobalt-induced podosomes are able to locally degrade the ECM, we 
performed an in vitro matrix degradation assay based on loss of FITC-conjugated gelatin. 
Macrophages induced localised degradation as shown by dark areas in the fluorescent-tagged 
gelatin matrix (indicated by arrows in Fig. 6A). The degradation of gelatin was closely 
associated with cells expressing podosomes and in some cases, the podosomes were located 
directly over the degraded matrix (Fig. 6A). Both Co2+ and CoNPs promoted matrix degradation 
(Fig. 6B), with associated statistically significant differences in matrix degradation index (Fig. 
6C). Treatment with Cr3+ and CrNPs had no significant effect on the ECM degradation (Fig. 6B). 
The matrix degradation by podosomes involves the recruitment and activation of matrix 
metalloproteinases (MMPs) [25]. Using a zymography assay we measured the release and 
activation of MMPs. We observed release of MMP9 (band at a molecular weight of 82-92 kDa) 
after cobalt treatment (Fig. 6D). Additionally, a lower band of 82 kDa molecular weight was 
observed indicating an active form of MMP9 cleaved from pro-MMP9. Co2+ and CoNPs 
induced pro-MMP9 release was not concentration-dependent, while the formation of active 
MMP9 was (Fig. 6E). Cobalt exposure had no significant effect on MMP2 release. 
Immunofluorescent staining revealed that intracellular MMP9 frequently co-localised with 
cobalt-induced podosomes (Fig. S3). In line with the results shown in Fig. 6B, Cr3+ and CrNPs 
did not cause any significant change in the release of MMP2, pro-MMP9 nor the active form 






Figure 6. Enhanced ECM degradation induced by cobalt is associated with the release and 
activation of MMP9, which co-localizes with podosomes. (A) Representative fluorescence 
microscopy image showing FITC-conjugated gelatin (green) degraded by U937 macrophages 
counter stained for F-actin (red) podosomes. Associated fluorescence intensity measurements 
demonstrate the co-localization of areas of gelatin degradation and the F-actin podosomes. 
Scale bar indicates 10 µm. (B) Representative images showing FITC-conjugated gelatin 
degradation following 24 h treatment with Co2+ (200 µM), CoNPs (100 µM), Cr3+ (400 µM) or 
CrNPs (400 µM) and untreated control. Scale bar indicates 20 µm. (C) Associated 
measurements of degradation area quantified as degradation index normalized to control 
group show significantly increased degradation following cobalt treatments. Values represent 
mean + SEM for N=3 with n=10 fields of view per experiment. (D) Zymography gels showing 
the release and activation of MMP9 by U937 cells due to cobalt treatment. (E) Quantification 
of the formation of pro-MMP9, active MMP9 and MMP2 based on gelatin zymography results, 
values represent mean + SEM for N=5. All statistically significant differences between different 
groups and control were determined by one way ANOVA and Bonferroni’s multiple 
comparison test; *P < 0.05, **P < 0.01, ***P < 0.001.  
3.7 Inhibition of macrophage migration in the presence of cobalt was associated with ROS 
production and its down-regulation of RhoA expression.  
Heavy metal ions and nanoparticles can provoke cellular stress, which may lead to alterations 
in cellular structure and function, and potentially loss of cell viability [26]. Both Co2+ and CoNPs 
induced ROS in a concentration-depended manner in U937 macrophages, and we showed that 
this also occurs at non-cytotoxic concentrations (Fig. 7A). The maximum increase in ROS 
production of approximately 90% compared to unstimulated cells, occurred within the first 30 
minutes. This significant increase persisted for 4 hours of treatment but decreased after 6 





at 2 hours, with an increase of approximately 75% at 150 µM (Fig. 7B). Co-treatment with ROS 
scavenger and antioxidant, NAC (N-acetyl-L-cysteine), abolished the cobalt-induced ROS 
production in cells (Fig. 7A, B). We next tested whether ROS generation was responsible for 
the cobalt-induced podosome formation and the consequent inhibition of U937 macrophage 
migration. Co-treatment of Co2+-treated cells with NAC resulted in a reduction in the cobalt-
induced podosome formation (Fig. 7C, D) and a significant increase in Co2+-treated 
macrophage transmigration (Fig. 7E). As mitochondria and NADPH oxidases are the main 
sources of cellular ROS, we also tested the effect of a NADPH oxidase inhibitor apocynin (5 
μM, 10 μM and 50 μM). However, apocynin was not able to inhibit cobalt-mediated ROS 
generation nor to restore macrophage migration (data not shown), which suggested that 
cobalt-mediated ROS increases are mainly mitochondria-derived.  
Actin organisation and podosome turnover are tightly regulated by the Rho GTPase, such as 
RhoA, Rac1 and Cdc42, whose activity is determined by their guanine nucleotide-bound state 
[27]. To determine if cobalt-induced ROS acts as an upstream regulator to activate Rho 
GTPases, we investigated the expression of RhoA, Cdc42 and Rac1 after U937 macrophages 
were treated by Co2+ (200 µM) and CoNPs (100 µM) for 24 hours. As shown in Figure 7F, G, 
cobalt did not affect the Rac1 and Cdc42 levels, but caused decreased RhoA expression 
indicating that Co2+ and CoNPs negatively regulate RhoA signalling. This was further confirmed 
by down-regulation of the downstream proteins of RhoA signalling, such as pMLC (phospho-
myosin Light Chain) and pMYPT (phospho-myosin-binding subunit of myosin phosphatase).  
In addition, the treatment of macrophages with the RhoA-specific inhibitor C3 Transferase (2 
μg/ml) and RhoA/ROCK1 pathway inhibitor Y-27632 (20 µM) also led to intensive cell 
spreading and increased podosome formation (Fig. 7H) as observed in cobalt-treated cells. 
Accordingly, the migration of U937 macrophages were also significantly impaired when RhoA 
signalling was inhibited by inhibitor C3 Transferase and Y-27632 (Fig. 7H, I). Furthermore, the 
reduced expression of RhoA level caused by Co2+ and CoNPs was significantly reversed by using 
the NAC (Fig. 7J, K), which has showed to suppress the cobalt-induced ROS generation and be 
capable of partially restore the migration ability of U937 macrophages. These data suggest 
that cobalt-induced ROS production lies upstream of the RhoA signalling and down-regulation 















Figure 7. Cobalt stimulates ROS production which stimulates podosome formation and 
impedes macrophage migration. (A, B) Dose and time dependent ROS production induced by 
Co2+ and CoNPs; values represent mean + SEM from N=3 separate experiments. Statistically 
significant differences determined by one-way ANOVA and Bonferroni’s multiple comparison 
test. (**P < 0.01; ***P < 0.001, (*** indicates significant upregulation for all of the three 
concentrations). (C) Fluorescence images showing that the ROS inhibitor, NAC (5 mM, 12 h) 
prevents Co2+ induced upregulation of podosome formation as shown by F-actin labelling with 
phalloidin and quantified in (D), data with median shown from one representative experiment 
out of three; significance was determined by Mann-Whitney test. ***P < 0.001; N=3. (E) 
Suppression of U937 macrophage transmigration is rescued by treatment with NAC. Data 
indicates the mean + SEM for number of migrated cells per field of view from 3 separate 
experiments, N=3, with n=10 fields of view per experiment (# P < 0.05, ##/**P < 0.01; 
###/***P < 0.001). Scale bars represents 10 µm. (F) Western blots results for untreated cell 
and cells treated with Co2+ (200 µM) and CoNPs (100 µM) for 24 hours. (G) The corresponding 
quantification demonstrating decreased RhoA expression. Values represent mean + SEM; *** 
indicate difference from control, P < 0.001; N=3. (H) Representative images showing the 
effects of inhibitor C3 Transferase and Y-27632 on U937 macrophage cytoskeleton 
organization and migration. (I) Quantification of the effects of C3 Transferase and Y-27632 on 
U937 macrophage organization. Values represent mean + SEM. N=3. For each experiment, 10 
random fields were imaged for each treatment (n=10). **P < 0.01. (J) Western blots results 
showing RhoA level reduced by Co2+ and CoNPs could be partially restored by inhibition of ROS 
with NAC (5 mM). (K) The corresponding quantification of cellular RhoA level with treatment 
by Co2+, CoNPs and NAC.  Values represent mean + SEM; ** indicate difference from control, 
P < 0.01; N=3. Scale bars represents 10 µm in (C) and (H).  
4. Discussion 
Macrophages play an essential role in surveillance and coordination of the inflammatory 
cascade associated with implant stability. The production of CoCr alloy wear debris leads to 
phagocytosis of the particles by macrophages [28]. This metal debris with associated ions 
activate the monocyte/macrophage lineage to release a variety of mediators, such as free 
radicals, nitric oxide, tumour necrosis factor-α (TNF-α), interleukin-1 β (IL-1 β), prostaglandin 
E2 (PGE2) and IL-6 [29-32], which are influenced by the concentrations, shape and size of the 
particles [4]. Metal debris and ions can sensitize the immune system by inducing a delayed 
type IV hypersensitivity response [33]. Moreover, CoCr nanoparticles have been shown to be 
able to induce DNA damage and chromosomal aberration across cellular barriers [34]. In our 
study we elucidated the mechanism of altered macrophage behaviour by metal ions and 
particles at non-cytotoxic concentrations.   
We used a combined in vitro and in vivo approach to examine the differential response of 
macrophages to cobalt and chromium ions and nanoparticles. Using a range of techniques, 
we have demonstrated for the first time that non-toxic levels of cobalt significantly reduce 
macrophage migration due to impaired egress capacity of macrophages. We have also further 
elucidated the underpinning molecular mechanism, which involves down-regulation of RhoA 
expression through induced ROS production. These findings provide new mechanistic 
explanation of the extensive clinical failures of orthopaedic implants manufactured from CoCr 
alloys, which are associated with retention of the macrophages and consequent prolonged 
and unrestrained inflammatory reactions that could lead to implant failure ultimately. In 
particular, the present in vitro results revealed that relatively low levels of both Co2+ ions (100 
PM) and CoNPs (200 PM) markedly inhibit the random migration and chemotaxis of both 
U937 macrophages and murine bone marrow derived macrophages (BMDM), while Cr3+ and 





peritoneal macrophage efflux experiment, where we found that CoNPs inhibit the 
macrophage emigration from the cavity triggered by LPS (Fig. 3).  
The mechanisms of the particulate-mediated inflammatory response associated with the 
imbalance in tissue homeostasis remains unclear, although a retention of macrophages within 
periprosthetic tissues is often reported [35, 36]. We report, for the first time, that the 
retention of macrophages during cobalt exposure is associated with an increase in both 
podosome formation and cell spreading (Fig. 5). These morphological and structural changes 
associated with macrophage retention are dependent on ROS formation (Fig. 7). Additionally, 
during increased podosome formation, an increase in MMP9 production occurs, resulting in a 
greater matrix degradation, all driven in a cobalt concentration-dependant manner (Fig. 6).  
This mechanism reducing macrophage migration in response to Co2+ ions and CoNPs, may 
provide new therapeutic targets to control the tissue response and minimise the potential of 
subsequent implant failure.  
The mechanism of cell migration is controlled by a co-ordinated turnover of the actin and 
microtubule cytoskeletal network [37]. Migration is regulated by actin polymerization with 
actin/myosin interactions forming contractile forces to retract the cell, while microtubules 
specify migration directionality [38]. When studying the effect of cobalt and chromium on 
these critical components of the cell migration machinery, we observed a slightly decrease in 
the acetylation of α-tubulin in response to CrNPs, without affecting cell motility (Fig. 4 and 2). 
In contrast, cobalt increased α-tubulin acetylation while inhibiting cell migration. To test 
whether increased acetylation initiates the inhibition of macrophage migration, we induced 
tubulin acetylation with Tubastatin A, a potent HDAC6 inhibitor [22]. Tubastatin A treatment 
resulted in higher levels of α-tubulin acetylation than cobalt, and a reduction in macrophage 
migration, but to a smaller extend than cobalt (Fig. 4E). These results indicate either a non-
specificity of Tubastatin A or that the migration response to cobalt involves additional 
mechanisms.    
Apart from tubulin modifications, we found that cobalt induced alteration in macrophage 
morphology by enhancing cell spreading and an increase in the number and density of 
podosomes (Fig. 5A and D). Both cell spreading and podosomes formation involve the 
deformation of a cell membrane and the strengthening of cell–substrate attachment [39, 40]. 
Podosome-type adhesions are rich in vinculin and other types of adhesion proteins, and 
regulate cell adhesion to the ECM [40]. Cell spreading and short-lived podosome formations 
with their adhesion structures are associated with enhanced macrophage migration and 
invasion [27]. When either process is uncontrolled, cell migration can be hindered [41]. For 
example, the inflammatory mediator PGE2 promotes macrophage migration in response to 
chemotactic signals, but at high doses, it reduces macrophage chemotaxis by enhancing cell-
substratum adhesion [24]. In our study, we confirmed that the non-toxic concentrations of 
Co2+ led to a concentration-dependent increase in cell adhesion to the ECM substrate (Fig. 5F, 
G). These results suggest that the reduction in macrophage migration induced by cobalt is due 
to both the increased cell spreading and the enhanced podosome formation.  
We also found that the molecular mechanisms through which cobalt regulates podosome 
adhesion and reduced migration, involves the formation of ROS (Fig. 7). Both Co2+ and CoNPs 
were shown to promote generation of the oxidative stress and increase ROS levels in vitro [42, 
43]. ROS is generated as a by-product during cellular oxidative metabolism, although its 
overproduction enhances cellular oxidative stress, transforming cells so they are unable to 
maintain normal physiological functions [44, 45]. ROS are also the key signalling molecules 
during the progression of inflammatory disorders [46], by modulating the production of 
inflammatory chemokines and expression of leukocyte adhesion receptors to accumulate 





may further facilitate macrophage accumulation and their activation, resulting in prolonged 
inflammation. Our findings indicate that the mechanism behind ROS role in the retention of 
infiltrated macrophages at the inflamed sites is through regulating the cytoskeleton 
reorganization.   
The cytoskeleton reorganization in presence of ROS is driven by the ability of ROS to induce 
reversible oxidation of proteins, which involves direct modification of protein kinases and 
transcription factors [47]. Major regulators of macrophage motility and cytoskeleton 
organization are influenced by Rho family GTPase [48-50], F-actin regulation pathways [51] 
and tyrosine phosphorylation [52, 53]. The Rho family of GTPases play critical roles in cell 
motility by affecting actin organization and microtubule dynamics, myosin activity, and cell–
ECM and cell–cell interactions [54]. In this study, we showed for the first time that cobalt-
induced ROS formation acts as an upstream regulator to directly inactivate the RhoA, leading 
to reorganization of macrophage cytoskeleton and impaired cell migration (Fig. 7F-K). Small 
GTPase Rho is known to stimulate stress fiber formation and hamper the cell migration in 
many types of cells [55]. It is even reported that inactivation of Rho in transformed fibroblasts 
by dominant negative RhoA or the C3 exoenzyme would disrupt podosome structure [56], but 
also that podosome formation in Src-transformed fibroblasts could be promoted by limiting 
Rho activation [57]. In addition, it was recently revealed that podosome disassembly is 
associated with the activation of Rho and blockade of RhoA signalling, and could promote 
actin core assembly and podosome formation in macrophages [58].  
Underlying mechanisms through which biomaterials-induced ROS formation modulates 
macrophage behaviour are of considerable importance. Despite emerging advances in 
materials science, biomaterials do not behave like native biological components and 
frequently incite adverse tissue reactions, which may lead to ultimate failure of the implants. 
Therefore accurate and facile approaches for screening and evaluating the biocompatibility of 
biomaterials are of critical interest, especially understanding the cellular behaviour of 
macrophages because of their decisive role in the long term survival of implanted biomaterials 
in addition to orchestrating inflammatory processes.   
Over recent years, the use of MoM total hip replacement is in a drastic decline due to CoCr-
related issues. However, implants containing CoCr alloys are still being widely utilized, such as 
in dental prosthesis and modular heads in MoP couplings. Significant increase in the amount 
of metal ion released into the saliva of patients with dental metallic materials has been 
reported [59]. Modular taper junctions allow for patient-specific fitting of implants. However, 
numerous retrieval studies have recently documented the adverse tissue reactions and 
pseudotumor formation adjacent to taper junctions in hip implants [5, 7], which are clinically 
and histologically similar to ALTRs previously seen in failed MoM bearing. The etiology of this 
soft-tissue damage is also linked to release of metal ions and debris from the modular taper 
junctions. Therefore, further investigation is required to elucidate these different, yet similar, 
exposure scenarios. More importantly, a comprehensive biological evaluation of metal 
exposure is necessary due to the potentially destructive nature of these adverse reactions.  
We acknowledge several limitations in this study. Although we have provided an explicit 
demonstration of the effect of cobalt on macrophage migration behaviour via a range of in 
vivo and in vitro techniques, it is still unknown whether macrophage accumulation around 
MoM hips is caused by a defective migratory ability. A refined animal study with in vivo 
tracking of macrophage recruitment would facilitate further investigation and yield improved 
understanding. Using commercially available nanoparticles in place of cobalt and chromium 
wear debris allowed us to decipher the individual role of the two primary elements in the 
cellular response. Possible synergistic effect of these two metals is of importance and should 





macrophages were used for data consistency, instead of primary human macrophages. These 
cellular models excluded the influence of variability in cells from different human donors, as 
have been used as in vitro cell models to study responses to orthopaedic wear products 
including bone cement, polyethylene, ceramic, metal particles, as well as metal ions [32, 60-
62]. Findings of our current study, can help us design further investigations using primary 
human cells to characterize individual patient’s responses to the wear debris.  
5. Conclusion  
Our study identified a new downstream effect of cobalt-induced ROS production and reduced 
RhoA expression in modulating macrophage migration and cytoskeleton organization. The 
effects of this signalling cascade lead to an enhancement in macrophage spreading, adhesion 
and inhibition of migration, which could lead to a prolonged immune cell retention thereby 
propagating the chronic inflammation. The increased podosome formation in macrophages is 
also associated with enhanced activation of MMP9 and associated increased matrix 
degradation. The identification of this new mechanism through which cobalt, but not 
chromium, ions and nanoparticles induce macrophage retention at inflammatory sites 
provides a novel insight into the metal-associated periprosthetic tissue lesions.  
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Supplementary Information  
 
 
Figure S1. Physical characterization of CoNPs and CrNPs. Transmission electron microscope 
images of CoNPs (upper left), CrNPs (upper right). Measured polydispersity index (PDI) and 
zeta potential of the respective NPs in serum containing cell culture medium. Scale bar 
indicates 100 nm. 
 
Figure S2. Cytotoxic effects of cobalt ions and nanoparticles on the differentiated U937 cells 
(a, b) and BMDMs (c, d) over 24 hours. Statistical analysis: One-way ANOVA with Bonferroni 
post-test: ***p<0.01, for treatment and control. (Cell viability was evaluated when exposed 
to Cr3+ and CrNPs at concentrations ranging from 100 – 800 μM. None of these concentrations 







Figure S3 Confocal immunofluorescence localisation of MMP-9 (green) in U937 macrophages 
after cobalt treatment (200 µM Co2+ and 100 µM CoNPs) reveal co-localisation with F-actin 
podosomes (red). Scale bar indicates 20 μm.   
 
Figure S4. Cobalt increased the percentages of cells forming podosomes. Staining and of 
podosome formation (A), quantification of alteration in cell area (B) and percentages of cell 
forming podosmes in BMDMs after treatments; arrows: podosomes in BMDMs; significance 
was determined by one-way ANOVA and Bonferroni’s multiple comparison test; *P < 0.05, 
**P < 0.01; Scale bar indicates 10 µm.    
